|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2006-6-23
|
|
pubmed:abstractText |
This study aimed to determine whether the plasma levels of matrix metalloproteinase-9 (MMP-9) or tissue inhibitor of metalloproteinases-1 (TIMP-1) were altered in patients with a history of symptomatic in-stent restenosis (ISR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e121-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16690873-Aged,
pubmed-meshheading:16690873-Cholesterol, HDL,
pubmed-meshheading:16690873-Coronary Angiography,
pubmed-meshheading:16690873-Coronary Restenosis,
pubmed-meshheading:16690873-Female,
pubmed-meshheading:16690873-Humans,
pubmed-meshheading:16690873-Male,
pubmed-meshheading:16690873-Matrix Metalloproteinase 9,
pubmed-meshheading:16690873-Middle Aged,
pubmed-meshheading:16690873-Retrospective Studies,
pubmed-meshheading:16690873-Severity of Illness Index,
pubmed-meshheading:16690873-Stents,
pubmed-meshheading:16690873-Tissue Inhibitor of Metalloproteinase-1
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.
|
|
pubmed:affiliation |
Section of Surgery, University of Otago, Dunedin, New Zealand. greg.jones@otago.ac.nz
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
